Literature DB >> 33864834

Modified Superior Capsule Reconstruction Using the Long Head of the Biceps Tendon as Reinforcement to Rotator Cuff Repair Lowers Retear Rate in Large to Massive Reparable Rotator Cuff Tears.

Chen-Hao Chiang1, Leo Shaw2, Wei-Hsing Chih3, Ming-Long Yeh4, Hsiao-Hsien Ting5, Chang-Hao Lin3, Chao-Ping Chen6, Wei-Ren Su7.   

Abstract

PURPOSE: To retrospectively assess the clinical outcomes of the patients with large to massive reparable RCTs treated by arthroscopic rotator cuff repair (ARCR) combined with modified superior capsule reconstruction (mSCR) using the long head of biceps tendon (LHBT) as reinforcement with a minimum of 2 years of follow-up.
METHODS: We retrospectively evaluated 40 patients with large to massive reparable RCTs who underwent ARCR and mSCR (group I) between February 2017 and June 2018 (18 patients) or underwent ARCR and tenotomy of LHBT performed at the insertion site (group II) between January 2015 and January 2017 (22 patients). The pain visual analog score (VAS) was assessed preoperatively and 1, 3, 6, 12, 24 months postoperatively. American Shoulder and Elbow Surgeons (ASES) scores, the University of California, Los Angeles (UCLA) shoulder rating scale, and active range of motion (AROM) were assessed before surgery and 6, 12, and 24 months after surgery. The integrity of the rotator cuff and mSCR was evaluated using magnetic resonance images at 12 months postoperatively.
RESULTS: After surgery, both groups had significantly improved in VAS, ASES, UCLA and AROM scores in the final follow-up. There were no significant between-group differences in the characteristics of the patients before surgery. Group I had improved pain relief at 1 month (P < .001) and at 3 months (P < .01) after surgery. For the AROM, group I (flexion, external rotation, internal rotation) demonstrated better improvement than group II 6 months after surgery (all P < .05) and better internal rotation 12 and 24 months after surgery (all P < .05). The mSCR survival rate was 94.4% (17/18). The retear rate of repaired rotator cuffs for groups I and II was 16.7% (3/18) and 40.9% (9/22), respectively, and the differences were significant (P < .046).
CONCLUSIONS: ARCR combined with mSCR using LHBT as reinforcement may lead to a lower retear rate and earlier functional recovery than conventional ARCR with tenotomy of LHBT for large to massive reparable RCTs. LEVEL OF EVIDENCE: Level III, retrospective therapeutic comparative trial.
Copyright © 2021 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33864834     DOI: 10.1016/j.arthro.2021.04.003

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  5 in total

Review 1.  [Research progress of arthroscopic long head of biceps tendon transposition in treatment of irreparable massive rotator cuff tears].

Authors:  Binbin Deng; Xueqiang Deng; Shuaigang Liu; Liang Hao
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-02-15

2.  Use of an Arthroscopic Bridging Graft for Irreparable Rotator Cuff Tears With the Modified Mason-Allen Stitch Using a Tendon Autograft.

Authors:  Sam-Guk Park; Hyun-Gyu Seok
Journal:  Arthrosc Tech       Date:  2022-04-22

3.  Arthroscopic Biological Augmentation for Massive Rotator Cuff Tears: The Biceps-Cuff-Bursa Composite Repair.

Authors:  Deepak N Bhatia
Journal:  Arthrosc Tech       Date:  2021-09-14

4.  Identification of Diagnostic Biomarkers Associated with Stromal and Immune Cell Infiltration in Fatty Infiltration After Rotator Cuff Tear by Integrating Bioinformatic Analysis and Machine-Learning.

Authors:  Si Wang; Jin-He Ying; Huan Xu
Journal:  Int J Gen Med       Date:  2022-02-19

5.  Arthroscopic-Assisted Lower Trapezius Tendon Transfer With Autologous Semitendinosus Tendon and Long Head of Biceps Superior Capsule Reconstruction for Massive Irreparable Posterosuperior Rotator Cuff Tears.

Authors:  Chih-Hao Chiu; Cheng-Pang Yang; Hao-Che Tang; Chun-Jui Weng; Kuo-Yao Hsu; Alvin Chao-Yu Chen; Yi-Sheng Chan
Journal:  Arthrosc Tech       Date:  2022-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.